Neurology

Neurofibromatosis

The Indiana University Neurofibromatosis Clinic is based at Riley Hospital for Children at IU Health. It is the only clinic for comprehensive care of those with neurofibromatosis in the state of Indiana.

IU School of Medicine scientists have been leaders in researching the molecular basis of neurofibromatosis and developing new treatment options based on the work. For example, IU School of Medicine investigators discovered that the anti-cancer drug Gleevec could be used as a therapy in neurofibromatosis type 1, making it the first effective treatment for the tumors affecting many NF1 patients.

Program Director

Laurence E. Walsh, MD

Laurence E. Walsh, MD

Associate Professor of Clinical Neurology